Vigabatrin in the treatment of epilepsy: A long-term follow-up study

A. Tartara; R. Manni; C. A. Galimberti; J. P. Mumford; A. Iudice; E. Perucca

Vigabatrin in the treatment of epilepsy: A long-term follow-up study

A. Tartara, R. Manni, C. A. Galimberti, J. P. Mumford, A. Iudice, E. Perucca

Fondazione "Istituto Neurologico Casimiro Mondino"

Research output: Contribution to journal › Article › peer-review

Abstract

Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.

Original language	English
Pages (from-to)	467-471
Number of pages	5
Journal	Journal of Neurology, Neurosurgery and Psychiatry
Volume	52
Issue number	4
Publication status	Published - 1989

ASJC Scopus subject areas

Psychiatry and Mental health
Neuroscience(all)
Neuropsychology and Physiological Psychology

Access to Document

Fingerprint Dive into the research topics of 'Vigabatrin in the treatment of epilepsy: A long-term follow-up study'. Together they form a unique fingerprint.

Cite this

@article{fe35ab1fec1f4449bb534eba7a14c13a,

title = "Vigabatrin in the treatment of epilepsy: A long-term follow-up study",

abstract = "Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.",

author = "A. Tartara and R. Manni and Galimberti, {C. A.} and Mumford, {J. P.} and A. Iudice and E. Perucca",

year = "1989",

language = "English",

volume = "52",

pages = "467--471",

journal = "Journal of Neurology, Neurosurgery and Psychiatry",

issn = "0022-3050",

publisher = "BMJ Publishing Group",

number = "4",

}

TY - JOUR

T1 - Vigabatrin in the treatment of epilepsy

T2 - A long-term follow-up study

AU - Tartara, A.

AU - Manni, R.

AU - Galimberti, C. A.

AU - Mumford, J. P.

AU - Iudice, A.

AU - Perucca, E.

PY - 1989

Y1 - 1989

N2 - Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.

AB - Twenty-five adult epileptic patients who had shown a satisfactory clinical response to add-on vigabatrin under placebo-controlled conditions continued on long-term treatment for up to 47 months (median 22 months). The initially favourable therapeutic response was generally maintained throughout the observation period with an overall good clinical tolerance. No evidence of neurotoxicity was detected by multimodal evoked potentials monitoring.

UR - http://www.scopus.com/inward/record.url?scp=0024562589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024562589&partnerID=8YFLogxK

M3 - Article

C2 - 2661725

AN - SCOPUS:0024562589

VL - 52

SP - 467

EP - 471

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 4

ER -